EyeControl (אייפרי תקשורת מסייעת)

Tel Aviv, Israel

Medical Devices Remote Monitoring Acute & Hospital Care Clinical Workflow

EyeControl is an assistive technology for intensive care units. The device uses pupil movements to enable bi-directional remote communication between ventilated patients and medical staff, thereby improving accuracy of care, freeing up beds and equipment, and limiting contagion by reducing the need for proximity. EyeControl has two target markets: medical facilities for ventilated patients and home care for locked-in individuals. EyeControl will pilot the medical device at hospitals treating patients with COVID-19, where it can help preserve lines of communication between ventilated patients and nurse stations outside quarantine. EyeControl is CE marked, FDA listed, and ISO certified. The company concluded a clinical trial in the intensive care unit at the Tel Aviv Sourasky Medical Center and is scheduled to conduct an expanded trial at Emory University Hospital. In 2019, commercialization of the EyeControl home care device commenced in Israel and the United Kingdom. The device is reimbursed by the Israel Ministry of Health, UK National Health Service, and U.S. Centers for Medicare and Medicaid Services.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out EyeControl (אייפרי תקשורת מסייעת) on @MedStartr Today #CriticalCare #AcuteCare #RespiratoryFailure #AllTherapeuticAreas #MedicalDevices #RemoteMonitoring #AcuteHospitalCare #ClinicalWorkflow #MedMo #MedStartrVentures

https://www.medstartr.ai/s/mUzHgfSZhOw

Get Involved in EyeControl (אייפרי תקשורת מסייעת)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2016
Website: www.eyecontrol.co.il/

Disease Areas

Critical Care Acute Care Respiratory Failure All Therapeutic Areas

Technologies

Assistive TechnologyMedical DevicesCommunication TechRemote Monitoring

🌐Website

What do you think of EyeControl (אייפרי תקשורת מסייעת)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.